Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MLWCV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2022253035A1 ADC-35
|
|||||
| Synonyms |
WO2022253035A1 ADC 35
Click to Show/Hide
|
|||||
| Organization |
Sichuan Kelun Pharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 3 Indication(s)
Colorectal cancer [ICD11:2B91]
Investigative
Gastric cancer [ICD11:2B72]
Investigative
Pancreatic cancer [ICD11:2C10]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.8
|
|||||
| Structure |
|
|||||
| Antibody Name |
19F6_Hu35v1
|
Antibody Info | ||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
WO2022253035A1 ADC-35 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.